Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Contributors

Seok-Min Kang: (View ORCID Profile)

Yangsoo Jang: (View ORCID Profile)

Geu-Ru Hong: (View ORCID Profile)

Journal

Title: Circulation

Abbreviated Title: Circulation

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Print): 0009-7322

ISSN (Electronic): 1524-4539

Publication date Created: February 02 2021

Publication date (Print): February 02 2021

Volume: 143

Issue: 5

Pages: 510-512

Affiliations

[1 ]Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea (C.Y.S., J.S., I.C., C.J.L., S-M.K., J-W.H., Y.J., G-R.H.).

[2 ]Division of Cardiology, Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Korea (I-J.C.).

[3 ]Department of Cardiology, The Second General Hospital, Ulaanbaatar, Mongolia (P.L.).

[4 ]College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences and Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea (G.H.).

Article

DOI: 10.1161/CIRCULATIONAHA.120.051992

PubMed ID: 33186508

SO-VID: a29a3346-c0cb-4a24-96de-ba6ba2a3fc33

History

Data availability:

Comments

Comment on this article

scite_

Cited by 25

See all cited by

Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus : The IDDIA Trial

Read this article at